Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
Health Tools
 In & Outs of Eye Cream
 Beaty: How To Rejuventate Your Eyes
 Eye & Vision Problems
 Video: Detecting Dry Eye
 LASIK Surgery
Featured Conditions
 Allergy
 Sleep
 Migraine
 Diabetes
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

New Treatment for 'Lazy Eye' Shows Promise

U.S., Chinese project finds 90% of vision gains retained 1 year after therapy


Related Encyclopedia
 border=
Acoustic Neurinoma
Barotitis Media
Cataracts
Central Serous Retinopathy
More...

Related Animations
 border=
LASIK
More...

Related Healthscout Videos
 border=
Targeting Tumors
New Treatment for Macular Degeneration
Detecting Dry Eye
NEW ALLERGY DROPS
More...

Related News Articles
 border=
Health Tip: Is Your Child More Prone to Ear Infections?
Blood Sugar Control Helps Diabetics Preserve Sight
Poor Night Vision May Predict Age-Related Eye Disease
U.S. Gets a 'D' for Preterm Birth Rates
More...

TUESDAY, March 4 (HealthDay News) -- A new treatment for lazy eye shows promise in adults, say American and Chinese researchers who found the therapy worked well in 20-year-old volunteers.

Lazy eye, also known as amblyopia, has been considered irreversible after age 8. Many people with the condition, especially those in developing countries, are diagnosed too late for conventional treatment with an eye patch, the researchers noted.

Text Continues Below



This new method, called perceptual learning, involves training with a simple visual task to improve vision.

A pilot trial at a Beijing hospital found that 28 of 30 patients showed dramatic gains after a 10-day course of treatment with the new method, said research group leader Zhong-Lin Lu, a University of Southern California neuroscientist.

"After training, they start to use both eyes. Some people got to 20/20. By clinical standards, they're completely normal. They're not amblyopes anymore," Lu said in a prepared statement.

The gains among the patients averaged two to three lines on a standard eye chart. Previous research found that the improvement is long-lasting, with 90 percent of vision gain retained at least one year after the therapy.

The research was described in a study published in this week's online issue of the Proceedings of the National Academy of Sciences.

Amblyopia, which can't be corrected with glasses, affects about 3 percent of people. Symptoms of the disorder include poor vision in one eye, poor depth perception, difficulty seeing three-dimensional objects, and poor motion sensitivity. Amblyopia is caused by poor transmission of images from the eye to the brain during early childhood, leading to abnormal brain development, according to background information in a new release about the research.

While this new perceptual learning therapy shows promise, it hasn't been proven to be effective in a clinical setting, noted Dennis Levi, dean of optometry at the University of California, Berkeley.

"It's clear that perceptual learning in a lab setting is effective. However, ultimately, it needs to be adopted by clinicians, and that will probably require multi-center trials," Levi said in a prepared statement.

More information

The U.S. National Eye Institute has more about amblyopia.



-- Robert Preidt

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 3/4/2008

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.





SOURCE: University of Southern California, news release, March 3, 2008


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service    

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.